CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Format: Artigo
Jezik:Russo
Izdano: IRBIS LLC 2016-02-01
Serija:Фармакоэкономика
Teme:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Online dostop:https://www.pharmacoeconomics.ru/jour/article/view/130
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki